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Abstract
Background: Telehealth has emerged as a crucial component of the SARS-CoV-2 pandemic emergency response. Simply
stated, telehealth is a tool to provide health care from a distance. Jefferson Health has leveraged its acute care telehealth platform
to screen, order testing, and manage patients with COVID-19–related concerns.
Objective: This study aims to describe the expansion and results of using a telehealth program to increase access to care while
minimizing additional potential exposures during the early period of the COVID-19 pandemic.
Methods: Screening algorithms for patients with SARS-CoV-2–related complaints were created, and 150 new clinicians were
trained within 72 hours to address increased patient demand. Simultaneously, Jefferson Health created mobile testing sites
throughout eastern Pennsylvania and the southern New Jersey region. Visit volume, the number of SARS-CoV-2 tests ordered,
and the number of positive tests were evaluated, and the volume was compared with preceding time periods.
Results: From March 8, 2020, to April 11, 2020, 4663 patients were screened using telehealth, representing a surge in visit
volume. There were 1521 patients sent to mobile testing sites, and they received a telephone call from a centralized call center
for results. Of the patients who were tested, nearly 20% (n=301) had a positive result.
Conclusions: Our model demonstrates how using telehealth for a referral to central testing sites can increase access to
community-based care, decrease clinician exposure, and minimize the demand for personal protective equipment. The scaling of
this innovation may allow health care systems to focus on preparing for and delivering hospital-based care needs.
(JMIR Mhealth Uhealth 2020;8(10):e20419) doi: 10.2196/20419
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Introduction
The SARS-CoV-2 (COVID-19) pandemic presented the need
to rapidly evolve the traditional in-person care model to distance
treatment. Due to infection control considerations for clinicians
and patients in higher-risk health care settings as well as
worldwide shortages of personal protective equipment (PPE),
telehealth became a crucial component to emergency health
care [1-3]. Telehealth involves a remote medical encounter
between two clinicians or between a patient and a clinician, and
can be used for direct patient care at home, remote consults to
http://mhealth.jmir.org/2020/10/e20419/
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specialists, and chat visits asynchronously [4-9]. Due to the
current pandemic, telehealth has been quickly leveraged to
safely keep people at home, disseminate information, allow
decisions around testing to be made, coordinate testing when
appropriate, and risk stratify patients for evidence-based and
resource efficient care. In the time of COVID-19, the benefit
of telehealth seems obvious: a patient can be seen remotely,
assessed, and evaluated for need of testing, all without a visit
to the doctor’s office or to the emergency department (ED). A
remote visit potentially prevents an in-person patient care visit
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and facilitates timely and responsive patient-centered care
[10-12].
Jefferson Health, based in Philadelphia, Pennsylvania, created
a system-wide program, JeffConnect, in 2015 that included an
on-demand program, remote consults, scheduled visits for
postoperative or primary care, and virtual rounds. When cases
of SARS-CoV-2 abruptly increased around the world, Jefferson
Health prepared. The health care system’s organizing plan was
similar to that of other hospital settings: source more PPE; create
further surge capacity; procure surge ventilators, critical
equipment, and medications; streamline evaluation and
management protocols; and cross-train staff. Essential to this
plan was the additional incorporation of the on-demand acute
care telehealth program, hereby referred to as JeffConnect,
staffed by emergency medicine (EM) physicians already licensed
in Pennsylvania, New Jersey, and Delaware. The institution
was uniquely positioned to rapidly leverage this as an access
point for care and link to SARS-CoV-2 testing. Although
national telehealth companies also offer expanded services, they
generally do not have local community integration and are often
unable to offer testing and follow-up that is geographically
linked to patient location. Jefferson Health, with its JeffConnect
program and expanded services within its geographic region,
did not have this limitation.
The first COVID-19 cases in Pennsylvania were reported on
March 6, 2020. A state of emergency was declared in New
Jersey on March 9, 2020, and a public outreach campaign
regarding the ability to use telehealth for screening and an
emphasis on the need for people to socially distance was
launched at the same time. Jefferson Health (located in
southeastern Pennsylvania and southern New Jersey) saw the
increase in telehealth patient calls starting simultaneously early
March.
Herein we aim to outline our real-time telehealth intervention
at the start of the COVID-19 case surge in the region. We
delineate how to integrate telehealth and testing sites to decrease
clinician and patient exposure in a health care setting, maximize
efficient use of PPE, and increase safe access to
COVID-19–related testing and management in the community
setting.

Methods
Program Overview
With the intention of preventing unnecessary COVID-19
exposures, many primary care providers, onsite clinics, and
urgent cares in the region began to direct patients to consider
telehealth first for noncritical complaints. JeffConnect is staffed
24 hours a day by physicians and sees a variety of acute care
complaints, with visit times averaging less than 10 minutes.
Patients require an internet connection and a smartphone, tablet,
or computer, or access to one to use the platform. They pay the
one-time out-of-pocket fee, or a reduced copay if they are a
Jefferson employee. Due to this convenience, patients were
directed to JeffConnect as the first viable solution for COVID-19
complaint screening and evaluation.
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At the same time, a team composed of infectious disease
specialists, health system clinical leadership, and occupational
medicine leadership created screening protocols to determine
who should be tested from the community, which groups of
employees should be tested if they first contacted JeffConnect,
and who could stay at home with guidance on self-isolation
(due to limited testing capacity). Initial screening protocol
developed during implementation considered limited testing
capacity and prioritized COVID-19 infections in patients who
presented with fever or symptoms of acute respiratory illness,
were at the highest risk of exposure, were at a higher risk of
developing severe disease, or were at a high risk of exposing
others. Testing was recommended for patients who were
symptomatic with one of the following: close contact with
confirmed case, international travel within 14 days, at risk for
severe disease including chronic medical conditions, residents
of congregate settings, health care workers, patients who were
hospitalized, and those presenting with acute respiratory illness
without apparent cause. During the study period, patients who
were asymptomatic were not recommended for testing.
Once mobile testing sites were operationalized and linked to
JeffConnect on March 13, 2020, a SARS-CoV-2 lab order was
placed in the electronic health record order entry system. After
the order was placed by a clinician, the JeffConnect visit ended.
Patients were instructed to contact a centralized call center,
named Seamless Access. Seamless Access was a hub for patients
to coordinate their on-site testing. The call center group
completed the patient registration, confirmed that an order was
placed, provided directions and times to present to a testing site,
and provided patient education on what to expect upon arrival
and in the follow-up.
All test results from the electronic health record were routed to
a dedicated results follow-up team and separated into positive
and negative result pools. Data was extracted from the electronic
medical record and stored on secure systems consistent with
medical center policies. Patient data was deidentified for
aggregate analysis. Every patient tested was contacted via
telephone and received counseling on results, a re-evaluation
of symptoms, and advice on when to return to work or seek
additional care. For positive results, patients were contacted by
a designated primary care physician or nurse practitioner. For
negative results, patients were contacted by primary care nurse
care coordinators. Home isolation for patients who were
symptomatic was emphasized regardless of the result, given the
possibility for false-negative results. Patients with access to the
online patient portal were able to view their results immediately
and received additional written instructions based on a positive
or negative result. Each week, the number of patients, number
of SARS-CoV-2 tests performed, and positive results were
tracked for quality improvement processes and to inform
considerations on testing capacity.

Staffing Telehealth
Considering more limited access to ambulatory visits, patients
rapidly sought care via JeffConnect for COVID-19–related
complaints as well as for other acute complaints that they were
not able to see their primary care physician about. The goal was
for patients who were generally well to be evaluated and
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 10 | e20419 | p. 2
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determine if they required testing or were safe to stay home
(Figure 1).
Due to the opening of the testing sites and the aforementioned
goals, the prior staffing model of one EM physician managing
JeffConnect visits, even with the expectation of seeing four
patients an hour, was not sufficient to keep up with the abrupt
increase in patient volume. JeffConnect’s leadership had to scale
their process quickly to remotely evaluate a large volume of
patients. To allow patients to be seen in a timely manner, during
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the weekend of March 13-15, 2020, 150 new physicians from
internal medicine (IM), family medicine (FM), anesthesia, and
EM advanced practice providers (APPs) were trained remotely
using Zoom (Zoom Video Communications, Inc) and
myJeffHub, an internal video education platform accessible to
all employees. New clinician accounts were created by the
JeffConnect Medical Director and all clinicians were given the
training videos, tip sheets, screening protocols, and Jefferson
policies.

Figure 1. JeffConnect screening and testing process.

The IM and FM physicians added additional coverage from the
hours of 7 AM to 10 PM starting on March 15, 2020. IM and
FM physicians, due to licensing constraints, only covered
patients in Pennsylvania, while the EM staff would cover
Pennsylvania, New Jersey, and Delaware. Other clinicians
(anesthesia and APPs) were kept in reserve as needed for surge
capacity. For EM faculty, contingency planning included
ensuring those in high-risk groups such as those 60 years and
older or who were immunocompromised were also trained for
JeffConnect to convert in-person shifts to telehealth. The IM
and FM practices converted a number of their patient visits to
telehealth or rescheduled routine visits for later. At that time,
there was no emergency state reciprocity for licensure, so most
of the additional physicians covered patients from Pennsylvania
only. The newly trained clinicians and the existing telehealth
EM physician were able to meet the increased patient demand.
Over the next week, the ED redistributed staff physicians and
APPs to account for the fluctuating patient volumes. Clinicians
deemed high risk for COVID-19 complications were restaffed
to telehealth. JeffConnect leaders added a swing shift to increase
the IM and FM staffing from 10 AM to 7 PM. New Jersey
amended its licensing process, allowing for emergency
temporary licensure. This allowed more physicians to provide
telehealth to New Jersey patient callers.
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During the testing period, we evaluated the visit volume, number
of SARS-CoV-2 tests ordered, and number of positive tests.
JeffConnect visit volumes from the same period in 2019 and
the 5-week time interval preceding this 5-week study period
were evaluated for comparison. Descriptive statistics were used
in the analysis.

Results
In the telehealth screening and testing study period (March 8,
2020, to April 11, 2020), 4663 patients were evaluated and 1521
(33%) were recommended for SARS-CoV-2 testing. Peak
volumes for visits and testing occurred the week of March 15-21
with 1303 visits and 40% (n=527) of those patients sent for
testing (Figure 2).
There was an increase in telehealth patient volume from 321
visits from March 8 to April 11 in 2019 to 4663 visits during
the same dates in 2020. There were 653 total visits in the 5
weeks preceding the study period (February 2 to March 7, 2020),
compared to 4663 during the study period. This represents a
greater than seven-fold increase in visit volume. Of the 1521
patients that were tested, nearly 20% (n=301) had a positive
result.
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Figure 2. JeffConnect visit volumes and testing.

Discussion
Principal Findings
The abrupt rise in telehealth visit volume and COVID-19–related
testing need, as well as the approximately 20% (301/1521)
positive rate during our study period mirrors the numbers in
Pennsylvania, with a 18% positive rate in the state during the
same time period (129,207 SARS-CoV-2 tests with 23,340
positive cases in Pennsylvania) [13]. This coincides with the
initial surge of COVID-19 cases in the northeast of the United
States during this time period [14]. This suggests our screening
algorithms and indications for testing, considering constrained
testing resources, were similar to those being used in the region
during the study period [13].
It is unclear how many in-person evaluations were prevented,
and many of the new patients to JeffConnect were seen for
evaluation of COVID-19 symptoms or exposures. We believe
our surge in volume was also due to patients seeking care for
other urgent complaints via telehealth to avoid in-person contact
with the health care clinicians. The goal of quickly scaling
telehealth capacity was to keep viral exposure at a minimum,
and we suspect that receiving at-home screening kept patients
from exposing others in person and potentially spared exposure
for concerns not related to COVID-19. Considering the ongoing
nature of the COVID-19 pandemic, it is not yet clear whether
our region has reached its ultimate peak surge, and time will
tell if this intervention significantly impacts access to care,
testing, and appropriate isolation.

Process Replication
The JeffConnect telehealth COVID-19 innovation came together
by the alignment of multiple factors. The region had more time
than some other regions: time to write, organize, and execute
health system–wide policies, and to evolve previous emergency
management preparations for this specific context. As already
stated, Jefferson had a pre-existing telehealth structure including
and not limited to a platform, a workflow process, training
guides, courses, and a quality assurance process. This allowed
the efficient and rapid scale-up to meet the need for more
http://mhealth.jmir.org/2020/10/e20419/
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clinicians to accommodate the increased number of patient
visits. We were able to use existing staffing and electronic health
record infrastructure to create multiple outpatient testing sites
near these hospitals and urgent cares.
The commitment to resourcing this service to scale rapidly led
to a successfully evolved program within just a few days. None
of the challenges have been insurmountable. To date, the
telehealth clinicians’ group can see patients in an efficient and
timely manner, and direct them for immediate testing at one of
seven sites. For systems seeking to replicate this process, we
recommend the following:
•

•

•

•

•
•

•
•

•

Establish patient care and testing algorithms that clearly
identify who needs to be tested, considering local testing
resources
Implement a telehealth software based on a clearly
identified use case. Due to the pandemic, many companies
have created quick and discounted implementations, and
clear definition of need will determine which solution is
the right one.
Train clinicians in telehealth: on technology, screening
processes, and converting in-person encounters to virtual
care
Identify physical sites that can be used for walk-up or
drive-thru testing, which are close to existing health system
infrastructure and convenient for patients to access while
maintaining infection prevention practices
Identify and train staff at the testing sites for clear and
specific roles
Identify the appropriate testing equipment and keep count
of testing swabs being used relative to supply chain
considerations
Create clear workflows for testing sites to direct swabs for
in-house lab versus send-out testing
Create team and process for follow-up on test results,
distancing, and disease process counseling via telephone,
chat, or phone app
Establish a quality assurance process for testing site staff,
telehealth clinicians, results reviewers, and any other groups
involved
JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 10 | e20419 | p. 4
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•
•

Create ongoing process improvements to address obstacles,
questions, and changes
Ensure that each step has specific team members and each
team has a specific role and defined leadership. This ensures
improved flow and efficiency, and allows challenges to be
quickly identified and fixed.

Limitations
We acknowledge certain limitations to this innovation. One
challenge appeared on Monday, March 16, 2020, when the
telehealth platform software functionality slowed in processing
speed. We quickly identified the cause, a large increase in the
number of clinicians seeing patients. This was rectified by
Teladoc by scaling the cloud-based resources. We considered
this a learning lesson; we needed to better anticipate technology
limitations and associated rapid growth in users.
Prior to centralization of testing and registration by Seamless
Access, patients were required to call separate telephone
numbers for different testing sites. Understandably, this caused
confusion for both patients and for clinicians. The addition of
Seamless Access and a centralized telephone number to call for
registration and testing site information streamlined the
workflow.
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There is a cost to the service, which can also be a barrier to
employing this model of care delivery, in addition to the
requirement for a smartphone, tablet, or computer and internet
connection among users that may limit this as an access point
to care.

Conclusion
Telehealth has arrived as a crucial component of testing and
treatment during the COVID-19 crisis. In a matter of days, our
use of telehealth transformed the way Jefferson Health was
providing patient care during a pandemic. Developing a
successful and scalable telehealth solution is allowing patients
to stay home and preserve hospital resources as much as
possible, receive testing for COVID-19 when appropriate, and
get directed to additional care when necessary. Additional
research will be required to determine the effectiveness of
telehealth in reducing exposures for health care workers and
the community. However, in this time of uncertainty, patients
are seeking evidence-based advice and the benefits of virtual
care have become clear to clinicians, patients, and the health
care system.

Acknowledgments
Publication made possible in part by support from the Thomas Jefferson University Open Access Fund.

Conflicts of Interest
None declared.

References
1.
2.
3.
4.
5.

6.

7.
8.
9.

10.

Ranney ML, Griffeth V, Jha AK. Critical supply shortages — the need for ventilators and personal protective equipment
during the COVID-19 pandemic. N Engl J Med 2020 Apr 30;382(18):e41. [doi: 10.1056/nejmp2006141]
Rational use of personal protective equipment ( PPE) for coronavirus disease ( COVID-19) : interim guidance. World
Health Organization. 2020 Mar 19. URL: https://apps.who.int/iris/handle/10665/331498
Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA 2020
May 19;323(19):1912-1914. [doi: 10.1001/jama.2020.5317] [Medline: 32221579]
Lew SQ, Sikka N. Operationalizing telehealth for home dialysis patients in the United States. Am J Kidney Dis 2019
Jul;74(1):95-100. [doi: 10.1053/j.ajkd.2019.01.023] [Medline: 30898363]
du Toit M, Malau-Aduli B, Vangaveti V, Sabesan S, Ray RA. Use of telehealth in the management of non-critical emergencies
in rural or remote emergency departments: A systematic review. J Telemed Telecare 2017 Oct 05;25(1):3-16. [doi:
10.1177/1357633x17734239]
Mullen-Fortino M, Rising KL, Duckworth J, Gwynn V, Sites FD, Hollander JE. Presurgical assessment using telemedicine
technology: impact on efficiency, effectiveness, and patient experience of care. Telemed J E Health 2019 Feb;25(2):137-142.
[doi: 10.1089/tmj.2017.0133] [Medline: 30048210]
Izzo J, Bhat R, Blumenthal J, Hoffman D, Watson J, Booker E. Diagnostic accuracy of a rapid telemedicine encounter in
the emergency department. Ann Emerg Med 2017 Oct;70(4):S127-S128. [doi: 10.1016/j.annemergmed.2017.07.394]
Slivinski A, Jones R, Whitehead H, Hooper V. Improving access to stroke care in the rural setting: the journey to acute
stroke ready designation. J Emerg Nurs 2017 Jan;43(1):24-32. [doi: 10.1016/j.jen.2016.10.006] [Medline: 28131346]
Creating a framework to support measure development for telehealth. National Quality Forum. 2017 Aug. URL: https:/
/www.qualityforum.org/publications/2017/08/creating_a_framework_to_support_measure_development_for_telehealth.
aspx
Hong Y, Lawrence J, Williams D, Mainous III A. Population-level interest and telehealth capacity of US hospitals in
response to COVID-19: cross-sectional analysis of Google search and national hospital survey data. JMIR Public Health
Surveill 2020 Apr 07;6(2):e18961 [FREE Full text] [doi: 10.2196/18961] [Medline: 32250963]

http://mhealth.jmir.org/2020/10/e20419/

XSL• FO
RenderX

JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 10 | e20419 | p. 5
(page number not for citation purposes)

JMIR MHEALTH AND UHEALTH
11.

12.
13.
14.

Joshi et al

Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. Telehealth for global emergencies:
implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020 Mar 20;26(5):309-313. [doi:
10.1177/1357633x20916567]
Hollander JE, Carr BG. Virtually perfect? Telemedicine for COVID-19. N Engl J Med 2020 Apr 30;382(18):1679-1681.
[doi: 10.1056/NEJMp2003539] [Medline: 32160451]
COVID-19 data for Pennsylvania. Department of Health of Pennsylvania. 2020. URL: https://www.health.pa.gov/topics/
disease/coronavirus/Pages/Coronavirus.aspx [accessed 2020-07-01]
Northeastern United States census region. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/
surveillance/nrevss/coronavirus/region.html#north [accessed 2020-09-01]

Abbreviations
APP: advanced practice provider
ED: emergency department
EM: emergency medicine
FM: family medicine
IM: internal medicine
PPE: personal protective equipment

Edited by G Eysenbach; submitted 18.05.20; peer-reviewed by P Chai, C Wu, S Omboni; comments to author 13.07.20; revised version
received 01.08.20; accepted 22.09.20; published 16.10.20
Please cite as:
Joshi AU, Lewiss RE, Aini M, Babula B, Henwood PC
Solving Community SARS-CoV-2 Testing With Telehealth: Development and Implementation for Screening, Evaluation and Testing
JMIR Mhealth Uhealth 2020;8(10):e20419
URL: http://mhealth.jmir.org/2020/10/e20419/
doi: 10.2196/20419
PMID:

©Aditi U Joshi, Resa E Lewiss, Maria Aini, Bracken Babula, Patricia C Henwood. Originally published in JMIR mHealth and
uHealth (http://mhealth.jmir.org), 16.10.2020. This is an open-access article distributed under the terms of the Creative Commons
Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete
bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license
information must be included.

http://mhealth.jmir.org/2020/10/e20419/

XSL• FO
RenderX

JMIR Mhealth Uhealth 2020 | vol. 8 | iss. 10 | e20419 | p. 6
(page number not for citation purposes)

